🎉 We celebrated 3 years of MSInsight with our partners, investors, and advisors — and what a journey it’s been.
Last week, surrounded by the ecosystem that’s helped shape our mission, we marked not only our THIRD anniversary, but also the successful close of our €1.6M fundraising round.
🙏 We’re deeply grateful to our investors —
Calyseed,Plateau de Saclay Business Angels, Yes Invest,Capital Cell, andBpifrance— and to the **Paris Saclay Cancer Cluster (PSCC)** for hosting the celebration in their inspiring premises.
A special thank you to our experts and advisors — Pr. Thierry André, MD, Florence Renaud, MD-PhD, and Alex Duval, MD-PhD — for their continued guidance and powerful reminder of why we do this work.
Their words emphasized both the urgency and opportunity: the clinical importance of MSI evaluation, its proven relevance for patients, and the diagnostic gaps that still need closing.
We’re proud of what we’ve built so far — a growing team, validated technology, and a clear path toward regulatory and clinical expansion — but even more motivated by what lies ahead.
To everyone who has contributed to our mission: thank you for believing in it.
**Arnaud Cutivet Sydney Normand MĂ©lyna Koutima Mathieu Daniere Sati Saakian Balthazar RAFFY Toky Ratovomanana Seif S.**
Â
